Search

Your search keyword '"Arango Ossa, Juan"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Arango Ossa, Juan" Remove constraint Author: "Arango Ossa, Juan"
48 results on '"Arango Ossa, Juan"'

Search Results

1. Molecular taxonomy of myelodysplastic syndromes and its clinical implications

2. Clonal evolution during metastatic spread in high-risk neuroblastoma

3. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

4. Unified classification and risk-stratification in Acute Myeloid Leukemia

5. Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs

6. A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

7. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes

8. Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

9. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

10. Supplementary Figure S5 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

11. Supplementary Table S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

12. Data from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

14. A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

15. Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

16. Data from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia

17. Supplementary Figure from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia

18. Supplementary Data from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia

19. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

20. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

22. Unmatched Whole-Genome Sequencing As a Clinical Tool for Hematological Neoplasms with Significant Utility in Cases with Tumor-in-Normal Contamination

23. Diagnostic Utility of Whole Genome Sequencing in Adults with B-Other Acute Lymphoblastic Leukaemia

24. Clonal evolution during metastatic spread in high-risk neuroblastoma

25. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

26. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.

27. Unified classification and risk-stratification in Acute Myeloid Leukemia

28. Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia

29. Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production

30. Chemotherapy-Related Mutational Signatures Reveal the Origins of Therapy-Related Myeloid Neoplasms

31. Isogenic MDS-RS Patient-Derived iPSCs Define the Mis-Spliced Transcript Repertoire and Chromatin Landscape of SF3B1-Mutant Hematopoietic Stem/Progenitor Cells

32. Deconvoluting Clonal and Cellular Architecture in IDH-Mutant Acute Myeloid Leukemia

33. Molecular Taxonomy of Myelodysplastic Syndromes and Its Clinical Implications

34. A D e Novo Supernumerary Ring Chromosome 1 Causes B-Cell Acute Lymphoblastic Leukemia in Monozygotic Twins Due to Independent and Partially Convergent Evolutionary Trajectories

35. Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors.

36. Clinical utility of whole genome sequencing in hematological neoplasms.

38. Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

39. Accelerated single cell seeding in relapsed multiple myeloma

40. Landscape of TP53 Mutations in MPN

41. TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes

42. Abstract 5105: A plug-and-play infrastructure for scalable bioinformatics operations

44. Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

45. UBA1Mutations Identify a Rare but Distinct Subtype of Myelodysplastic Syndromes

46. Diagnostic Utility of Comprehensive RNA-Seq Analysis in Adult B-ALL

47. A D e NovoSupernumerary Ring Chromosome 1 Causes B-Cell Acute Lymphoblastic Leukemia in Monozygotic Twins Due to Independent and Partially Convergent Evolutionary Trajectories

48. TP53State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes

Catalog

Books, media, physical & digital resources